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Background/Aims  :  We  investigated  the  prevalence  and  relationship  of  peptic  ulcer  disease  and  Helicobacter  pylori 
infection  to  liver  cirrhosis. 
Methods :  We  examined  288  patients  with  liver  cirrhosis,  322  patients  with  non-ulcer  dyspepsia,  and  339  patients 
with peptic ulcer disease. Rapid urease test and Wright-Giemsa staining were used for diagnosis of H. pylori infection. 
Results : The prevalence of peptic ulcer disease in patients with cirrhosis was 24.3%. The prevalence of peptic ulcer 
disease  in  patients  with  cirrhosis  divided  into  Child-Pugh  classes  A,  B,  and  C  was  22.3%,  21.0%,  and  31.3%, 
respectively  (p>0.05).  The  prevalence  of  H.  pylori i n f e c t i o n  i n  t h e  p a t i e n t s  w i t h  c i r r h o s i s ,  n o n - u l c e r  d y s p e p s i a ,  a n d  
peptic ulcer without chronic liver disease were 35.1%, 62.4%, and 73.7%, respectively (p<0.001). The prevalence of 
H. pylori infection did not differ depending on whether there was peptic ulcer (35.6%) or not (34.9%) in patients with 
liver  cirrhosis  (p>0.05).  The  prevalence  of  H. pylori infection in patients with hepatitis virus-related liver cirrhosis and 
in the patients with alcohol-related liver cirrhosis was 42.5% and 22.0%, respectively (p<0.001). The prevalence of H. 
pylori  infection  in  patients  with  Child-Pugh  classes  A,  B,  and  C  liver  cirrhosis  was  51.5%,  30.5%,  and  20.0%, 
respectively  (p<0.001). 
Conclusions : Factors other than H. pylori may be involved in the pathogenesis of peptic ulcer disease in the setting 
o f  l i v e r  c i r r h o s i s .
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INTRODUCTION
Chronic  liver  disease  and  its  complications  are  major  health 
problems.  Peptic  ulcer  disease  is  one  of  the  most  frequently 
observed  complications  in  patients  with  liver  cirrhosis.  Although 
the incidence and prevalence of peptic ulcer disease appear to 
be  increased  in  cirrhosis,  the  underlying  mechanism  of  peptic 
ulcer disease in cirrhosis is unclear
1-3). In the general population, 
Helicobacter  pylori  infection  is  central  to  the  pathogenesis  of 
peptic  ulcer  disease
4, 5).  H o w e v e r ,  t h e  r o l e  o f  H.  pylori  infection 
in  the  pathogenesis  of  peptic  ulcer  disease  in  cirrhotic  patients 
still  remains  to  be  elucidated.  Many  studies  have  suggested  a 
role  for  H.  pylori  infection  in  the  pathogenesis  of  peptic  ulcer 
disease  in  cirrhotic  patients,  but  several  studies  have  found  no 
relationship
6-24).  Moreover,  there  is  debate  concerning  the 
relationship  between  H.  pylori  infection  and  the  etiology  or 
severity  of  cirrhosis.
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(n=288)  (n=322)  (n=339)
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According  to  the  presence  of  PU
∥
without  PU  76/218  (34.9%)
with  PU  24/70  (35.6%)
¶
According  to  the  etiology  of  cirrhosis
 H B V
#  63/145  (43.4%)
  HCV
**  9/24  (37.5%)
  HBV  +  HCV  2/5  (40.0%)
  Alcoholic  24/109  (22.0%)
††
Cryptogenic  2/5  (40.0%)
According  to  the  Child-Pugh  class
  A  53/103  (51.5%)
  B  32/105  (30.5%)
C  16/80  (20.0%)
*Liver  Cirrhosis, 
†Non-Ulcer  Dyspepsia, 
‡Peptic  Ulcer  Disease, 
∥  Peptic  Ulcer, 
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Table  1.  The  prevalence  of  H.  pylori  infection  in  patients  with  liver  cirrhosis,  non-ulcer  dyspepsia,  and  peptic  ulcer  disease
ulcer  disease  and  H.  pylori  infection  in  patients  with  liver 
cirrhosis.  We  additionally  evaluated  the  relationship  between  H. 
pylori  infection  and  the  etiology  or  severity  of  cirrhosis. 
MATERIALS AND METHODS
The  study  population  included  288  consecutive  Korean 
patients (229 men and 59 women, 49.3±11.1 years of age) with 
newly diagnosed liver cirrhosis presenting at Chuncheon Sacred 
Heart  Hospital,  Hallym  University  Medical  Center,  Chuncheon, 
Korea,  between  January  2000  and  December  2004.  322  age- 
and sex-matched non-ulcer dyspepsia patients (259 men and 63 
women,  49.0±10.0  years  of  age)  without  chronic  liver  disease 
were drawn to serve as a control group. Additional ly, 339 age- 
and  sex-matched  peptic  ulcer  patients  (272  men  and  67 
women,  48.1±11.5  years  of  age)  without  chronic  liver  disease 
were  selected  as  a  reference  group.  Those  patients  who  had 
taken  antibiotics,  proton  pump  inhibitors,  or  non-steroidal 
anti-inflammatory  drugs  within  2  weeks  before  entry,  and  those 
patients  who  had  a  history  of  gastric  surgery,  were  excluded. 
Liver cirrhosis was diagnosed using a combination of clinical, 
biochemical,  radiologic,  and  histologic  methods.  The  severity  of 
cirrhosis  was  scored  according  to  the  Child-Pugh  classification. 
Etiology of the cirrhosis was defined as alcoholic if viral markers 
(HBsAg,  anti-HCV)  were  negative  and  there  was  a  history  of 
ethanol  intake  of  over  60  g/day  for  5  years  or  more.
All  the  enrolled  patients  underwent  upper  gastrointestinal 
endoscopy with 4 biopsies taken from the antrum (within 2 cm 
from  the  pylorus)  and  4  biopsies  taken  from  the  gastric  body 
(greater  curvature  side  of  the  midbody).  Endoscopy  was 
performed  using  an  Olympus  videoscope  GIF  240  (Olympus 
Optical Co., Ltd., Tokyo, Japan). Endoscopic diagnosis of peptic 
ulcer  disease  was  made  when  a  distinct  ulcer  crater  with 
fibrin-coated  base  larger  than  5  mm  was  observed.  The 
diagnosis  of  gastric  ulcer  was  always  confirmed  by  multiple 
biopsies  of  the  ulcer. 
F o u r  b i o p s y  s p e c i m e n s  2  f r o m  t h e  a n t r u m  a n d  2  f r o m  t h e  
gastric  body  were  used  to  identify  H.  pylori,  using  the  rapid 
urease  test  (CLOtest
Ⓡ,  B a l l a r d  M e d i c a l  P r o d u c t s ,  U T ,  U S A  o r  
ProntoDry
Ⓡ,  M e d i c a l  I n s t r u m e n t s  C o . ,  H e r f o r d ,  G e r m a n y ) .  F o u r  
other specimens 2 from the antrum and 2 from the gastric body 
were used for determining H. pylori presence (hematoxylin-eosin 
&  Wright-Giemsa  staining).  The  presence  of  H.  pylori  infection 
was  determined  by  positivity  of  rapid  urease  test  and/or 
histology  (Wright-Giemsa  staining).
This study was approved by the Hospital's Ethics Committee, 
and i nf or med cons ent  f or  endoscopy was  obt ai ned f rom al l  t he 
patients.
The  demographic  and  clinical  characteristics  were  analyzed 
statistically  using  the  chi-square  test  and  Spearman  correlation 
test,  as  appropriate.  A  value  of  p<0.05  was  considered  to  be 
statistically  significant.  Statistical  calculation  was  made  with  the 
help  of  SPSS  statistical  package  for  Windows  version  8.0.0. 
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Figure  1.  The  prevalence  of  peptic  ulcer  (A)  and H .  p y l o r i   infection  (B)  in  patients  with  liver  cirrhosis.  (A)  The  prevalence  of  peptic  ulcer  disease
in  cirrhotic  patients  is  not  significantly  different  according  to  Child-Pugh  class  (p>0.05).  (B)  A  negative  correlation  is  demonstrated  between  the 
prevalence  of  H.  pylori  infection  and  the  severity  of  liver  cirrhosis  according  to  Child-Pugh  class  (Spearman's  rho=-0.267,  p<0.001).
RESULTS
The etiologies of the 288 cirrhosis patients were: Hepatitis B 
virus (HBV)-related in 145, Hepatitis C virus (HCV)-related in 24, 
HBV  and  HCV-related  in  5,  alcohol-related  in  109,  and 
cryptogenic  in  5  patients. 
The prevalence of H. pylori infection in patients with cirrhosis, 
patients  with  non-ulcer  dyspepsia  without  chronic  liver  disease, 
and  peptic  ulcer  disease  patients  without  chronic  liver  disease, 
were 35.1% (101/288), 62.4% (201/322), and 73.7% (250/339), 
respectively. The prevalence of H. pylori infection in patients with 
cirrhosis  was  significantly  lower  than  in  non-ulcer  dyspepsia 
(p<0.001)  or  peptic  ulcer  disease  patients  without  chronic  liver 
disease  (p<0.001)  (Table  1).
The  point  prevalence  of  peptic  ulcer  disease  in  patients  with 
cirrhosis  was  24.3%  (36  gastric  ulcer,  31  duodenal  ulcer,  3 
gastric and duodenal ulcer). The prevalence of H. pylori infection 
was  35.6%  in  peptic  ulcer  disease  patients  with  liver  cirrhosis 
and 73.7% in peptic ulcer disease patients without chronic liver 
diseases (p<0.001). The prevalence of H. pylori infection did not 
differ  in  patients  with  liver  cirrhosis,  whether  peptic  ulcer  was 
present  (35.6%)  or  no  (34.9%)  (p>0.05)  (Table  1). 
The  prevalence  of  H.  pylori  infection  in  patients  with 
HBV-related,  HCV-related,  HBV-  and  HCV-related,  alcohol- 
related,  and  cryptogenic  liver  cirrhosis  was  43.4%,  37.5%, 
40.0%,  22.0%,  and  40.0%,  respectively.  The  prevalence  of  H. 
pylori  infection  in  patients  with  hepatitis  virus-related  liver 
cirrhosis  (42.5%)  was  significantly  higher  than  that  in  patients 
with  alcohol-related  liver  cirrhosis  (22.0%,  p<0.001)  (Table  1).
As shown i n Tabl e 1, t he preval ence of  H. pylori infection in 
p a t i e n t s  w i t h  C h i l d - P u g h  c l a s s  A ,  B ,  a n d  C  l i v e r  c i r r h o s i s  w a s  
51.5%,  30.5%,  and  20.0%,  respectively.  A  negative  correlation 
was noted between the prevalence of H. pylori infection and the 
severity  of  liver  cirrhosis  according  to  Child-Pugh  class 
(Spearman's  rho=-0.267,  p< 0 . 0 0 1 ) .  T h e  p r e v a l e n c e  o f  p e p t i c  
ulcer disease in cirrhotic patients according to Child-Pugh class 
A,  B,  and  C  was  22.3%,  21.0%,  and  31.3%,  respectively 
(p> 0 . 0 5 )  ( F i g u r e  1 ) .  
DISCUSSION
Although  the  point  prevalence  of  peptic  ulcer  disease  in 
patients  with  liver  cirrhosis  is  high,  reaching  24.3%,  the  exact 
mechanism  remains  to  be  determined.  The  high  prevalence  of 
peptic ulcer disease in patients in our study with liver cirrhosis is 
consistent  with  previous  reports
1-3, 6-8).
The  role  of  H.  pylori  infection  in  the  pathogenesis  of  peptic 
ulcer  disease  has  been  extensively  evaluated  in  non-cirrhotic 
patients
4, 5). The increased rate of peptic ulcer disease in patients 
w i t h  c i r r h o s i s  h a s  b e e n  e x p l a i n e d  i n  s o m e  s t u d i e s ,  b y  h i g h e r  
rates of gastric colonization with H. pylori
6, 7, 14-18, 23, 24). However, 
other  studies  have  found  no  relationship  between  H.  pylori 
infection  and  peptic  ulcer  disease  in  cirrhosis
9-12, 18-20).  For  a 
proper  interpretation  of  the  studies  investigating  the  prevalence 
of  H.  pylori i n f e c t i o n  i n  p a t i e n t s  w i t h  l i v e r  c i r r h o s i s ,  s e v e r a l  
factors,  such  as  diagnostic  methods,  etiology  of  liver  cirrhosis, 
and  geographic  and  racial  differences  in  H.  pylori p r e v a l e n c e  
should  be  considered. 
In  our  study,  the  prevalence  of  H.  pylori  infection  in patients 
with liver cirrhosis was 35.1%. Previous studies have reported a 
wide range (39～89%) in the prevalence of H. pylori infection in 
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patients with liver cirrhosis, most of them somewhat higher than 
our  study
7, 8, 12, 14, 17, 18).  Moreover,  the  prevalence  of  H.  pylori 
infection in cirrhotic patients in our study was significantly  lower 
than that in the control and reference groups, a finding that was 
different  from  that  found  by  many  groups
6, 7, 13-18, 23, 24).  It  was 
consistent  with  the  results  of  others
19, 20).  This  relatively  low 
prevalence of H. pylori infection in cirrhotic patients in our study 
can  be  explained  by  the  enrollment  of  more  than  50%  of 
Child-Pugh  B  and  C  cirrhotic  patients  in  our  study.  Although 
those  who  took  antibiotics  within  2  weeks  before  entry  were 
excluded, those who had a history of extensive but remote use 
of  antibiotics  were  included.  Therefore,  inclusion  of 
decompensated cirrhotic patients with a history of extensive but 
remote use of antibiotics due to various reasons might affect the 
prevalence  of  H.  pylori. 
The relatively low prevalence of H. pylori  infection  in  cirrhotic 
patients  in  our  study  can  also  be  partially  explained  by  the 
difference  in  the  diagnostic  methods  used  in  the  setting  of  H. 
pylori  infection.  In  general,  studies  that  use  serologic  tests  (IgG 
to  H.  pylori)  report  higher  prevalence  than  the  studies  that  use 
the rapid urease test, histology, or urea breath test for detection 
of  H.  pylori  infection  (76.2～89%  vs.  39～59.7%).  If  H.  pylori 
infection  and  liver  cirrhosis  have  the  same  risk  factors,  but  H. 
pylori  infection  cannot  easily  persist  in  the  stomach  of  cirrhotic 
patients,  serologic  determination  of  H.  pylori  infection  may  lead 
to confounding results. The 2007 Maastricht Consensus Report 
on  H.  pylori d i a g n o s i s  a n d  t r e a t m e n t  d o e s  n o t  r e c o m m e n d  
serological  determination  of  H.  pylori  infection  in  routine  clinical 
practice.  It  also  recommends  that  the  primary  diagnosis  of  H. 
pylori infection should be established by rapid urease test and/or 
histology
25-28). 
The  accuracy  of  gastric  mucosal  biopsy  may  be  affected  by 
various factors: the presence of bacteria other than H. pylori that 
produce  urease,  the  patch  distribution  of  H.  pylori i n  g a s t r i c  
mucosa, and the histologic overestimation of H. pylori due to the 
presence  of  confounding  bacteria.  Thus,  primary  diagnosis  by 
gastric mucosa biopsy urease testing and/or histology has some 
limitations
19).  So  the  accuracy  of  diagnostic  methods  use  to 
detect H. pylori infection in our study may affect the result of low 
prevalence  of  H.  pylori  infection.  The  concordance  of  rapid 
urease test and histology for the diagnosis of H. pylori infection 
i n  o u r  s t u d y  w a s  2 5 5  o u t  o f  2 8 8  i n  c i r r h o t i c  p a t i e n t s  a n d  2 9 3  
out of 339 in peptic ulcer patients without chronic liver disease.
The  prevalence  of  H.  pylori  infection  in  the  control  group  of 
the  present  study  (62.4%)  was  slightly  lower  than  the 
seroprevalence  (66.9%)  in  asymptomatic  Korean  adults
29).  This 
discrepancy  may  be  due  to  the  different  study  groups  and 
diagnostic methods. H. pylori infection in the general population 
correlates  with  age,  social  class,  education  level,  overcrowding, 
bed-sharing,  and  economic  level  during  childhood
13).  Thus,  a 
valid  comparison  of  the  prevalence  of  H.  pylori  infection  in 
patients  with  cirrhosis  and  the  general  population,  a  control 
group  matched  by  prognostic  variables  (age,  socioeconomic 
status,  ethanol  intake,  etc.)  would  be  required.  Although  our 
study used age- and sex-matched control and reference groups, 
socioeconomic  status  and  ethanol  intake  were  not  matched. 
Consequently,  out  study  may  not  provide  definitive  data. 
Besides  H.  pylori,  other  factors  may  contribute  to  the 
increased risk of peptic ulcer in cirrhotic patients
30, 31). Reduced 
prostaglandins, decreased gastric acid secretion, elevated serum 
gastrin  concentration,  impaired  mucus  secretion,  a  reduction  in 
potential  difference  of  the  gastric  mucosa,  and  portal 
hypertensive gastropathy may all play a role in the pathogenesis 
of  peptic  ulcer  disease  in  cirrhotic  patients
1-3).
Several studies have been previously performed regarding the 
relationship  between  the  prevalence  of  H.  pylori  infection  and 
peptic  ulcer  disease  according  to  the  etiology  and  severity  of 
liver  cirrhosis.  The  present  study  demonstrated  an  interesting 
finding  in  that  the  prevalence  of  H.  pylori  infection  in  patients 
with  liver  cirrhosis  varied  according  to  the  etiology  of  cirrhosis 
(viral  vs. a l c o h o l i c  =  4 2 . 5  vs.  22.0%,  p<0.001).  In  Korea,  HBV 
infection is still the leading cause of liver cirrhosis (53%), followed 
by  alcohol  (31%)  and  HCV  infection  (10%)
32).  Since  our  study 
included  a  relatively  small  proportion  of  cirrhotic  patients  with 
HCV infection, the fact that the prevalence of H. pylori infection 
in  virus-related  liver  cirrhosis  was  higher  than  that  in 
alcohol-related  cirrhosis  patients  may  not  be  generalizable  in 
other  countries  where  the  major  cause  of  liver  cirrhosis  is  HCV 
infection. 
It  is  of  interest  to  note  that  the  prevalence  of  H.  pylori 
infection  was  related  inversely  to  Child-Pugh  classification. 
A l t h o u g h  t h i s  o b s e r v a t i o n  i s  c o n s i s t e n t  w i t h  a  p r e v i o u s  r e p o r t ,  
which suggested that the prevalence of H. pylori infection among 
cirrhotic patients might be inversely related to the severity of liver 
cirrhosis,  many  previous  data  have  noted  no  relationship 
between H. pylori infection and severity of liver cirrhosis
8, 10, 11, 33,
34). Several factors, such as diagnostic methods, etiology of liver 
cirrhosis, proportion of decompensated cirrhosis, and geographic 
and  racial  differences  in  H.  pylori p r e v a l e n c e ,  m a y  e x p l a i n  t h e  
discrepancy.  Based  on  our  study,  we  hypothesize  that  the 
environment  of  the  stomach  in  cirrhotic  patients  may  not  be 
suitable for the growth of H. pylori, and the progression of liver 
disease  may  lead  to  a  more  hostile  milieu  to  H.  pylori.
Many  studies  have  argued  for  the  relationship  between  H. 
pylori  and  peptic  ulcer  in  cirrhotic  patients,  but  the  'statistically 
high'  (which  is  at  most  2  times  higher  than  control)  prevalence 
of  H.  pylori  in  cirrhotic  patients  in  those  studies  cannot  explain 
completely the 'vividly and absolutely high' (which is at least 10 
times higher  than control) prevalence of  peptic  ulcer in  cirrhotic 
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was decreased in patients with severe liver cirrhosis, peptic ulcer 
disease was increased. Based on our observations and those of 
others, we hypothesize that H. pylori may not be a main cause 
of  peptic  ulcer  disease  in  cirrhotic  patients
6). 
T h e  f o l l o w i n g s  a r e  m a j o r  f i n d i n g s  o f  o u r  s t u d y :  ( 1 )  E v e n  
though the prevalence of peptic ulcer disease was increased in 
patients with liver cirrhosis, H. pylori infection rate in peptic ulcer 
disease patients with cirrhosis was significantly lower than that in 
p a t i e n t s  w i t h o u t  c h r o n i c  l i v e r  d i s e a s e .  ( 2 )  T h e  p r e v a l e n c e  o f  H. 
pylori  infection  did  not  differ  in  patients  with  liver  cirrhosis, 
whether  there  was  peptic  ulcer  or  no.  (3)  Although  the 
prevalence  of  H.  pylori  infection  decreased  with  Child's  class 
progression,  the  prevalence  of  peptic  ulcer  disease  did  not 
change.  Taking  the  above  major  findings  into  account,  we  can 
conclude  that  H.  pylori i n f e c t i o n  m a y  n o t  b e  o n e  o f  t h e  m a i n  
factors  in  the  pathogenesis  of  peptic  ulcer  disease  in  patients 
with  liver  cirrhosis. 
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